Shopping Cart 0
Cart Subtotal
AED 0

Premier Biomedical Inc (BIEI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Premier Biomedical Inc (Premier Biomedical) is a drug development company that develops medications for debilitating and fatal illnesses. The company offers Feldetrex, a drug candidate used for the treatment of multiple sclerosis, fibromyalgia, blood sepsis and viremia, and cancer. It develops sequential-dialysis technique method that utilizes designer antibodies to physically remove the toxin-producing bacteria out of the blood. Premier Biomedical also provides medications for the treatment of amyotrophic lateral sclerosis, traumatic brain injury, clinical depression, Alzheimer's disease, atherosclerosis, and others. The company develops its technologies through laboratory, hospital, and clinical trials. Premier Biomedical is headquartered in Mercer, Pennsylvania, the US.

Premier Biomedical Inc (BIEI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Premier Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Premier Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 11

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 14

Asset Purchase 14

Premier Biomedical Acquires Rights To Potential Therapy For Retinitis Pigmentosa 14

Partnerships 15

Premier Biomedical and Advanced Technologies Solutions Form Joint Venture 15

Premier Biomedical and Auramedi Farmaceutica to Form Joint Venture 16

Premier Biomedical Enters Into R&D Agreement With William Beaumont Army Medical Center 17

Premier Biomedical Enters into Agreement with University of Texas at El Paso 18

Licensing Agreements 19

Premier Biomedical Amends its Licensing Agreement with University of Texas at El Paso 19

Equity Offering 20

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD0.8 Million 20

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD1.05 Million 21

Premier Biomedical Raises USD0.2 Million in Second Tranche of Private Placement of Shares and Warrants 22

Premier Biomedical to Raise Funds through Public Offering of Shares 23

Premier Biomedical Raises USD0.3 Million in First Tranche of Private Placement of Shares and Warrants 24

Premier Biomedical Withdraws Public Offering of Shares 25

Premier Biomedical Raises USD0.2 Million in Public Offering of Shares 26

Premier Biomedical Withdraws Public Offering of Shares 27

Premier Biomedical Completes Private Placement Of Shares For USD 5 Million 28

Premier Biomedical Completes Private Placement Of Shares For USD 0.07 Million 29

Premier Biomedical Completes Private Placement Of Shares For USD 0.15 Million 30

Premier Biomedical Completes Second Tranche Of Private Placement Of Units For USD 0.01 Million 31

Debt Offering 32

Premier Biomedical Raises Funds in Third Tranche of Private Placement of 10% Notes Due 2016 32

Premier Biomedical Raises USD0.1 Million in Private Placement of 10% Notes Due 2017 33

Premier Biomedical Raises USD0.1 million in Fifth and Final Tranche of Private Placement of 10% Notes Due 2016 34

Premier Biomedical Raises Funds in Fourth Tranche of Private Placement of 10% Notes Due 2016 35

Premier Biomedical Raises USD0.1 Million in Second Tranche of Private Placement of 10% Notes Due 2016 36

Premier Biomedical Raises USD1.6 Million in Private Placement of Notes 37

Premier Biomedical Raises USD0.2 Million in First Tranche of Private Placement of 10% Notes Due 2016 38

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 39

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 40

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 41

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 42

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 43

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 44

Premier Biomedical Raises Funds through Private Placement of 10% Notes Due 2015 45

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2014 46

Premier Biomedical Inc-Key Competitors 47

Premier Biomedical Inc-Key Employees 48

Premier Biomedical Inc-Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Joint Venture 49

Recent Developments 50

Strategy And Business Planning 50

Aug 21, 2018: Premier Biomedical creates four centers of technological expertise 50

Corporate Communications 51

Jul 30, 2018: Premier Biomedical uplifted to OTCQB 51

Product News 52

Jul 10, 2017: Premier Biomedical Introduces Improved Topical Skin Products 52

Jan 23, 2018: Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment 53

Other Significant Developments 54

Jul 10, 2018: Premier Biomedical CEO Update Letter-July, 2018 54

Feb 28, 2018: Premier Biomedical Searching For Development Partner To Advance Patent Pending Technology 56

Jul 13, 2017: Premier Biomedical Integrates CBD-Based Pain Relief Products Business; Expands Current and New Product Offerings 57

Feb 15, 2017: Multi-Pronged Product Distribution Agreements Announced by Premier Biomedical Pain Management Solutions for Their Superior Pain Relief Products 58

Jan 18, 2017: Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products 59

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60


List Of Figure

List of Figures

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Premier Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Premier Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Premier Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 10

Premier Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 11

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Premier Biomedical Acquires Rights To Potential Therapy For Retinitis Pigmentosa 14

Premier Biomedical and Advanced Technologies Solutions Form Joint Venture 15

Premier Biomedical and Auramedi Farmaceutica to Form Joint Venture 16

Premier Biomedical Enters Into R&D Agreement With William Beaumont Army Medical Center 17

Premier Biomedical Enters into Agreement with University of Texas at El Paso 18

Premier Biomedical Amends its Licensing Agreement with University of Texas at El Paso 19

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD0.8 Million 20

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD1.05 Million 21

Premier Biomedical Raises USD0.2 Million in Second Tranche of Private Placement of Shares and Warrants 22

Premier Biomedical to Raise Funds through Public Offering of Shares 23

Premier Biomedical Raises USD0.3 Million in First Tranche of Private Placement of Shares and Warrants 24

Premier Biomedical Withdraws Public Offering of Shares 25

Premier Biomedical Raises USD0.2 Million in Public Offering of Shares 26

Premier Biomedical Withdraws Public Offering of Shares 27

Premier Biomedical Completes Private Placement Of Shares For USD 5 Million 28

Premier Biomedical Completes Private Placement Of Shares For USD 0.07 Million 29

Premier Biomedical Completes Private Placement Of Shares For USD 0.15 Million 30

Premier Biomedical Completes Second Tranche Of Private Placement Of Units For USD 0.01 Million 31

Premier Biomedical Raises Funds in Third Tranche of Private Placement of 10% Notes Due 2016 32

Premier Biomedical Raises USD0.1 Million in Private Placement of 10% Notes Due 2017 33

Premier Biomedical Raises USD0.1 million in Fifth and Final Tranche of Private Placement of 10% Notes Due 2016 34

Premier Biomedical Raises Funds in Fourth Tranche of Private Placement of 10% Notes Due 2016 35

Premier Biomedical Raises USD0.1 Million in Second Tranche of Private Placement of 10% Notes Due 2016 36

Premier Biomedical Raises USD1.6 Million in Private Placement of Notes 37

Premier Biomedical Raises USD0.2 Million in First Tranche of Private Placement of 10% Notes Due 2016 38

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 39

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 40

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 41

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 42

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 43

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 44

Premier Biomedical Raises Funds through Private Placement of 10% Notes Due 2015 45

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2014 46

Premier Biomedical Inc, Key Competitors 47

Premier Biomedical Inc, Key Employees 48

Premier Biomedical Inc, Joint Venture 49

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Premier Biomedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Premier Biomedical Inc (Premier Biomedical) is a drug development company that develops medications for debilitating and fatal illnesses. The company offers Feldetrex, a drug candidate used for the treatment of multiple sclerosis, fibromyalgia, blood sepsis and viremia, and cancer. It develops sequential-dialysis technique method that utilizes designer antibodies to physically remove the toxin-producing bacteria out of the blood. Premier Biomedical also provides medications for the treatment of amyotrophic lateral sclerosis, traumatic brain injury, clinical depression, Alzheimer's disease, atherosclerosis, and others. The company develops its technologies through laboratory, hospital, and clinical trials. Premier Biomedical is headquartered in Mercer, Pennsylvania, the US.

Premier Biomedical Inc (BIEI)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Premier Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Premier Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 11

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 14

Asset Purchase 14

Premier Biomedical Acquires Rights To Potential Therapy For Retinitis Pigmentosa 14

Partnerships 15

Premier Biomedical and Advanced Technologies Solutions Form Joint Venture 15

Premier Biomedical and Auramedi Farmaceutica to Form Joint Venture 16

Premier Biomedical Enters Into R&D Agreement With William Beaumont Army Medical Center 17

Premier Biomedical Enters into Agreement with University of Texas at El Paso 18

Licensing Agreements 19

Premier Biomedical Amends its Licensing Agreement with University of Texas at El Paso 19

Equity Offering 20

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD0.8 Million 20

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD1.05 Million 21

Premier Biomedical Raises USD0.2 Million in Second Tranche of Private Placement of Shares and Warrants 22

Premier Biomedical to Raise Funds through Public Offering of Shares 23

Premier Biomedical Raises USD0.3 Million in First Tranche of Private Placement of Shares and Warrants 24

Premier Biomedical Withdraws Public Offering of Shares 25

Premier Biomedical Raises USD0.2 Million in Public Offering of Shares 26

Premier Biomedical Withdraws Public Offering of Shares 27

Premier Biomedical Completes Private Placement Of Shares For USD 5 Million 28

Premier Biomedical Completes Private Placement Of Shares For USD 0.07 Million 29

Premier Biomedical Completes Private Placement Of Shares For USD 0.15 Million 30

Premier Biomedical Completes Second Tranche Of Private Placement Of Units For USD 0.01 Million 31

Debt Offering 32

Premier Biomedical Raises Funds in Third Tranche of Private Placement of 10% Notes Due 2016 32

Premier Biomedical Raises USD0.1 Million in Private Placement of 10% Notes Due 2017 33

Premier Biomedical Raises USD0.1 million in Fifth and Final Tranche of Private Placement of 10% Notes Due 2016 34

Premier Biomedical Raises Funds in Fourth Tranche of Private Placement of 10% Notes Due 2016 35

Premier Biomedical Raises USD0.1 Million in Second Tranche of Private Placement of 10% Notes Due 2016 36

Premier Biomedical Raises USD1.6 Million in Private Placement of Notes 37

Premier Biomedical Raises USD0.2 Million in First Tranche of Private Placement of 10% Notes Due 2016 38

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 39

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 40

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 41

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 42

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 43

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 44

Premier Biomedical Raises Funds through Private Placement of 10% Notes Due 2015 45

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2014 46

Premier Biomedical Inc-Key Competitors 47

Premier Biomedical Inc-Key Employees 48

Premier Biomedical Inc-Locations And Subsidiaries 49

Head Office 49

Other Locations & Subsidiaries 49

Joint Venture 49

Recent Developments 50

Strategy And Business Planning 50

Aug 21, 2018: Premier Biomedical creates four centers of technological expertise 50

Corporate Communications 51

Jul 30, 2018: Premier Biomedical uplifted to OTCQB 51

Product News 52

Jul 10, 2017: Premier Biomedical Introduces Improved Topical Skin Products 52

Jan 23, 2018: Premier Biomedical Launches Hemp Oil Based Topical Pain Relief Ointment 53

Other Significant Developments 54

Jul 10, 2018: Premier Biomedical CEO Update Letter-July, 2018 54

Feb 28, 2018: Premier Biomedical Searching For Development Partner To Advance Patent Pending Technology 56

Jul 13, 2017: Premier Biomedical Integrates CBD-Based Pain Relief Products Business; Expands Current and New Product Offerings 57

Feb 15, 2017: Multi-Pronged Product Distribution Agreements Announced by Premier Biomedical Pain Management Solutions for Their Superior Pain Relief Products 58

Jan 18, 2017: Premier Biomedical Pain Management Solutions Announces Product Distribution Agreement of Their Superior Pain Relief Products 59

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60


List Of Figure

List of Figures

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10

Premier Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 11


List Of Table

List of Tables

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7

Premier Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9

Premier Biomedical Inc, Deals By Therapy Area, 2012 to YTD 2018 10

Premier Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 11

Premier Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12

Premier Biomedical Acquires Rights To Potential Therapy For Retinitis Pigmentosa 14

Premier Biomedical and Advanced Technologies Solutions Form Joint Venture 15

Premier Biomedical and Auramedi Farmaceutica to Form Joint Venture 16

Premier Biomedical Enters Into R&D Agreement With William Beaumont Army Medical Center 17

Premier Biomedical Enters into Agreement with University of Texas at El Paso 18

Premier Biomedical Amends its Licensing Agreement with University of Texas at El Paso 19

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD0.8 Million 20

Premier Biomedical Files Registration Statement for Public Offering of Shares for up to USD1.05 Million 21

Premier Biomedical Raises USD0.2 Million in Second Tranche of Private Placement of Shares and Warrants 22

Premier Biomedical to Raise Funds through Public Offering of Shares 23

Premier Biomedical Raises USD0.3 Million in First Tranche of Private Placement of Shares and Warrants 24

Premier Biomedical Withdraws Public Offering of Shares 25

Premier Biomedical Raises USD0.2 Million in Public Offering of Shares 26

Premier Biomedical Withdraws Public Offering of Shares 27

Premier Biomedical Completes Private Placement Of Shares For USD 5 Million 28

Premier Biomedical Completes Private Placement Of Shares For USD 0.07 Million 29

Premier Biomedical Completes Private Placement Of Shares For USD 0.15 Million 30

Premier Biomedical Completes Second Tranche Of Private Placement Of Units For USD 0.01 Million 31

Premier Biomedical Raises Funds in Third Tranche of Private Placement of 10% Notes Due 2016 32

Premier Biomedical Raises USD0.1 Million in Private Placement of 10% Notes Due 2017 33

Premier Biomedical Raises USD0.1 million in Fifth and Final Tranche of Private Placement of 10% Notes Due 2016 34

Premier Biomedical Raises Funds in Fourth Tranche of Private Placement of 10% Notes Due 2016 35

Premier Biomedical Raises USD0.1 Million in Second Tranche of Private Placement of 10% Notes Due 2016 36

Premier Biomedical Raises USD1.6 Million in Private Placement of Notes 37

Premier Biomedical Raises USD0.2 Million in First Tranche of Private Placement of 10% Notes Due 2016 38

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 39

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 40

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 41

Premier Biomedical Raises Funds through Private Placement of 12% Notes Due 2016 42

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 43

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2016 44

Premier Biomedical Raises Funds through Private Placement of 10% Notes Due 2015 45

Premier Biomedical Raises Funds through Private Placement of 8% Notes Due 2014 46

Premier Biomedical Inc, Key Competitors 47

Premier Biomedical Inc, Key Employees 48

Premier Biomedical Inc, Joint Venture 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Premier Biomedical Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.